ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Previous studies have identified significant variability in attention-deficit / hyperactivity disorder (ADHD) prevalence estimates worldwide, largely explained by methodological procedures. However, increasing rates of ADHD diagnosis and treatment throughout the past few decades have fuelled concerns about whether the true prevalence of the disorder has increased over time. METHODS: We updated the two most comprehensive systematic reviews on ADHD prevalence available in the literature. Meta-regression analyses were conducted to test the effect of year of study in the context of both methodological variables that determined variability in ADHD prevalence (diagnostic criteria, impairment criterion and source of information), and the geographical location of studies. RESULTS: We identified 154 original studies and included 135 in the multivariate analysis. Methodological procedures investigated were significantly associated with heterogeneity of studies. Geographical location and year of study were not associated with variability in ADHD prevalence estimates. CONCLUSIONS: Confirming previous findings, variability in ADHD prevalence estimates is mostly explained by methodological characteristics of the studies. In the past three decades, there has been no evidence to suggest an increase in the number of children in the community who meet criteria for ADHD when standardized diagnostic procedures are followed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“After adjusting for these factors, a subsequent meta-analysis concluded that the prevalence of ADHD does not significantly differ between countries in Europe, Asia, Africa and the Americas, as well as in Australia 3 .”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, even within communities there is marked variability in rates of ADHD due to the subjective nature of primarily descriptive (symptom-based) diagnostic procedures (Asherson et al., 2012; Polanczyk et al., 2014; see also recent reports by the US Center for Disease Control and Prevention).”
From Functional neuroimaging of visuospatial working memory tasks enables accurate detection of attention deficit and hyperactivity disorder (2015) · cites this paper as Polanczyk et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous research in children and adolescents has identified higher prevalence estimates based on research diagnosis via DSM-validated scales, compared to the prevalence based on the ICD-9 or ICD-10 diagnostic criteria (Polanczyk et al., 2007;Polanczyk et al., 2014), commonly used in register-based studies.”
From Prevalence of attention-deficit/hyperactivity disorder in older adults: a systematic review and meta-analysis (2020) · cites this paper as Polanczyk et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ADHD occurs throughout the developed and developing world”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as Polanczyk et al., 2014
The cited source says what the claim attributes to it.
In the citing paper
“Another meta-analysis, with 135 studies and about a quarter of a million youths, found no significant differences in prevalence between North America and Europe, Asia, Africa, South America, and Oceania”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as Polanczyk et al., 2014
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464 · cited 2×
“The ‘variance accounted for’ (VAF), a pseudo-R2 statistic, is given for each univariate model, indicating the percentage of the total heterogeneity in the true effects (heterogeneity) that is accounted for by each study-level variable (moderator) individually.(12) We also calculated the VAF for the model with all cova…”
MethodThe worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Self-citationNature-nurture reconceptualized in developmental perspective: A bioecological model.
Bronfenbrenner, U., & Ceci, S. J. (1994) · Psychological Review · doi:10.1037/0033-295x.101.4.568 · Cited by 2,973
Outlier and influence diagnostics for meta-analysis
Viechtbauer, W., & Cheung, M. W.-L. (2010) · Research Synthesis Methods · doi:10.1002/jrsm.11 · Cited by 2,949 · cited 1×
“Outlier and influential case diagnostics were performed using the externally standardized residuals, DFFITS values, Cook’s distances, covariance ratios, leave-one-out estimates of the amount of heterogeneity, leave-one-out heterogeneity test statistics, hat values and weights.(13) The analysis and graphical presentati…”
MethodGlobal Prevalence of Autism and Other Pervasive Developmental Disorders
Elsabbagh, M., Divan, G., Koh, Y., Kim, Y. S., Kauchali, S., Marcín, C., Montiel‐Nava, C., Patel, V., Paula, C. S., Wang, C., et al. (2012) · Autism Research · doi:10.1002/aur.239 · Cited by 2,636
The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
Willcutt, E. G. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0135-8 · Cited by 2,160 · cited 1×
“Further results detected significant heterogeneity between estimates, but once again country or region where the study was conducted did not explain the variability, supporting previous findings.(7) In addition, this study also did not address the effect of time on estimates.”
ResultSelf-citationEpidemiology of Pervasive Developmental Disorders
Fombonne, E. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7203 · Cited by 1,971 · cited 1×
“awareness and access to medical services may explain the increasing rates over time.(10) However, the possibility that a true increase in the incidence of ASD and also in ADHD”
BackgroundAttention-deficit hyperactivity disorder
Biederman, J., & Faraone, S. V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66915-2 · Cited by 1,463
Attention-deficit hyperactivity disorder and hyperkinetic disorder
Swanson, J., Sergeant, J., Taylor, E., Sonuga-Barke, E., Jensen, P., & Cantwell, D. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11450-7 · Cited by 601
Attention-deficit hyperactivity disorder and hyperkinetic disorder
Swanson, J. M., Sergeant, J. A., Taylor, E., Sonuga-Barke, E. J. S., Jensen, P. S., & Cantwell, D. P. (2001) · Attention Deficit Hyperactivity Disorders · doi:10.4324/9781315054315-2 · Cited by 572
Cited by
Items 101–200 of 1,004
Abel, M. H., Ystrøm, E., Caspersen, I. H., Meltzer, H. M., Aase, H., Torheim, L. E., Askeland, R. B., Reichborn‐Kjennerud, T., & Brantsæter, A. L. (2017) · Nutrients · doi:10.3390/nu9111239 · Cited by 119
“1% lower using the ICD-10 than the DSM-IV criteria [26].”
MethodRydell, M., Lundström, S., Gillberg, C., Lichtenstein, P., & Larsson, H. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12882 · Cited by 105
Bandeira, I. D., Guimarães, R. S. Q., Jagersbacher, J. G., Barretto, T. L., de Jesus-Silva, J. R., Santos, S. N., Argollo, N., & Lucena, R. (2016) · Journal of Child Neurology · doi:10.1177/0883073816630083 · Cited by 103
“1%(10) in children and adolescents and from 1% to 10% in adults.(10-12) This disorder is associated with alterations in neurotransmitters such as norepinephrine, serotonin, and especially dopamine.”
BackgroundLudyga, S., Brand, S., Gerber, M., Weber, P., Brotzmann, M., Habibifar, F., & Pühse, U. (2017) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2017.10.007 · Cited by 103
“Attention-Deficit/Hyperactivity Disorder (ADHD) is considered to be the most common neurodevelopmental disorder among children, with a global prevalence rate of 6% (Polanczyk et al., 2014).”
BackgroundCarucci, S., Balia, C., Gagliano, A., Lampis, A., Buitelaar, J. K., Danckaerts, M., Dittmann, R. W., Garas, P., Hollis, C., Inglis, S., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.031 · Cited by 103
“Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders (Polanczyk et al., 2014).”
BackgroundPrevalence of attention-deficit hyperactivity disorder (ADHD): systematic review and meta-analysis
Popit, S., Serod, K., Locatelli, I., & Štuhec, M. (2024) · European Psychiatry · doi:10.1192/j.eurpsy.2024.1786 · Cited by 164
Huß, M., Duhan, P., Gandhi, P., Chen, C., Spannhuth, C. W., & Kumar, V. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s130444 · Cited by 108
Zhang, L., Yao, H., Li, L., Du Rietz, E., Andell, P., Garcia-Argibay, M., D’Onofrio, B. M., Cortese, S., Larsson, H., & Chang, Z. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.43597 · Cited by 100
“2022;5(11):e2243597. doi:10.1001/jamanetworkopen.2022.43597 (Reprinted) November 23, 2022 9/15 Downloaded From: https://jamanetwork.com/ on 11/26/2022 We found that the risk of cardiovascular events associated with ADHD medications seemed to be higher among those with preexisting CVD compared with no prior CVD, althou…”
BackgroundInfluentialKeshavarzi, Z., Bajoghli, H., Mohammadi, M. R., Salmanian, M., Kirov, R., Gerber, M., Holsboer‐Trachsler, E., & Brand, S. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.922698 · Cited by 110
Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD
Kollins, S. H., Childress, A. C., Heusser, A. C., & Lutz, J. G. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00429-0 · Cited by 125
Bremberg, S. G. (2015) · Acta Paediatrica · doi:10.1111/apa.13075 · Cited by 113
“Most of the studies of children, and of externalising problems in adolescents, did not reveal a time trend (4), although many studies reported an increase in internalising problems in adolescents (3).”
BackgroundAssessing Heterogeneity in Random-Effects Meta-analysis
Langan, D. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1566-9_4 · Cited by 99
Heterogeneity in ADHD: Neurocognitive predictors of peer, family, and academic functioning
Kofler, M. J., Sarver, D. E., Spiegel, J. A., Day, T. N., Harmon, S. L., & Wells, E. L. (2017) · Child Neuropsychology · doi:10.1080/09297049.2016.1205010 · Cited by 94
Baggio, S., Fructuoso, A., Guimaraes, M., Fois, E., Golay, D., Heller, P., Perroud, N., Aubry, C., Young, S., Delessert, D., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00331 · Cited by 95
“Previous studies already demonstrated that methods have an effect on the prevalence estimate (5, 12).”
BackgroundMethodChan, A. Y. L., Ma, T.-T., Lau, W. C. Y., Ip, P., Coghill, D., Gao, L., Jani, Y. H., Hsia, Y., Wei, L., Taxis, K., et al. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101780 · Cited by 95
Dobrosavljevic, M., Solares, C., Cortese, S., Andershed, H., & Larsson, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.07.042 · Cited by 94
“, 2016) and meta-analyses in children, adolescents or younger adults (Polanczyk et al., 2007; Thomas et al., 2015; Simon et al., 2009; Polanczyk et al., 2014; Willcutt, 2012), with ADHD, by exploring potential differences between ADHD prevalence estimates based on different assessment methods.”
BackgroundResultKwon, S. J., Kim, Y., & Kwak, Y. (2018) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-018-0218-3 · Cited by 93
McKechnie, D. G., O’Nions, E., Dunsmuir, S., & Petersen, I. (2023) · BJPsych Open · doi:10.1192/bjo.2023.512 · Cited by 123
Curry, A. E., Metzger, K. B., Pfeiffer, M. R., Elliott, M. R., Winston, F. K., & Power, T. J. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.0910 · Cited by 91
“Using electronic health records, we defined a cohort of 2479 adolescents and young adults with ADHD and 15 865 without ADHD who were (1) born from 1987 to 1997; (2) residents of New Jersey and patients at 1 of 6 New Jersey primary care practices at age 12 years or older; and (3) age-eligible to obtain a driver’s licen…”
MethodPharmacogenetics predictors of methylphenidate efficacy in childhood ADHD
Myer, N. M., Boland, J. R., & Faraone, S. V. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.234 · Cited by 91
Gupte-Singh, K., Singh, R. R., & Lawson, K. A. (2017) · Value in Health · doi:10.1016/j.jval.2017.01.007 · Cited by 91
Rohner, H., Gaspar, N., Philipsen, A., & Schulze, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021275 · Cited by 90
“Moreover, a meta-regression analysis showed that the geographical location and year of study were not associated with variability in ADHD prevalence estimates [9].”
BackgroundElia, J., Ungal, G., Kao, C., Ambrosini, A. P., Jesus-Rosario, N. D., Larsen, L., Chiavacci, R. M., Wang, T., Kurian, C. J., Titchen, K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02244-2 · Cited by 95
Roles of age, gender and psychological difficulties in adolescent mentalizing
Poznyak, E., Morosan, L., Perroud, N., Speranza, M., Badoud, D., & Debbané, M. (2019) · Journal of Adolescence · doi:10.1016/j.adolescence.2019.06.007 · Cited by 91
Assessing ADHD symptoms in children and adults: evaluating the role of objective measures
Emser, T. S., Johnston, B. A., Steele, J. D., Kooij, S., Thorell, L., & Christiansen, H. (2018) · Behavioral and Brain Functions · doi:10.1186/s12993-018-0143-x · Cited by 89
Misiak, B., Wójta-Kempa, M., Samochowiec, J., Schiweck, C., Aichholzer, M., Reif, A., Samochowiec, A., & Stańczykiewicz, B. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110581 · Cited by 107
“Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder which affects about 5.2% of children and 2.6% of adults (Polanczyk et al., 2007, 2014; Song et al., 2021).”
BackgroundInfluentialDoidge, J., Flora, D. B., & Toplak, M. E. (2018) · Journal of Attention Disorders · doi:10.1177/1087054718815588 · Cited by 94
“ADHD is also one of the most commonly assessed neurodevelopmental disorders and the diagnosis rate has been increasing among children and adults (Polanczyk, Willcutt, Salum, Kieling, & Rohde, 2014; Visser et al., 2014).”
A systematic meta-review of systematic reviews on attention deficit hyperactivity disorder
Chaulagain, A., Lyhmann, I., Halmøy, A., Widding‐Havneraas, T., Nyttingnes, O., Bjelland, I., & Mykletun, A. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2451 · Cited by 111
Cibrian, F. L., Lakes, K. D., Schuck, S. E. B., & Hayes, G. R. (2021) · International Journal of Child-Computer Interaction · doi:10.1016/j.ijcci.2021.100421 · Cited by 109
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Rasmussen, P. D., Huus, C.-M. L., Zwi, M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub3 · Cited by 164
Attenuated Tonic and Enhanced Phasic Release of Dopamine in Attention Deficit Hyperactivity Disorder
Badgaiyan, R. D., Sinha, S., Sajjad, M., & Wack, D. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137326 · Cited by 84
“Attention deficit hyperactivity disorder (ADHD) is the most common psychiatric condition of childhood [1].”
BackgroundLugo, J., Fadeuilhe, C., Gisbert, L., Setien, I., Delgado, M., Corrales, M., Richarte, V., & Ramos-Quiroga, J. A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.07.004 · Cited by 81
Bonvicini, C., Faraone, S. V., & Scassellati, C. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1282175 · Cited by 83
“The ADHD prevalence was estimated to be 5.3% in childhood (Polanczyk et al. 2007, 2014; Willcutt 2012) and 2.5–4.9% in adulthood (Simon et al. 2009; Ramos- Quiroga et al. 2014a).”
BackgroundInfluentialThe Association between Lead and Attention-Deficit/Hyperactivity Disorder: A Systematic Review
Donzelli, G., Carducci, A., González, A. L., Verani, M., González, A. L., Cioni, L., & Morales‐Suárez‐Varela, M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16030382 · Cited by 95
“Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common mental disorders affecting children [1].”
BackgroundTourette syndrome and other neurodevelopmental disorders: a comprehensive review
Cravedi, E., Deniau, E., Giannitelli, M., Xavier, J., Hartmann, A., & Cohen, D. (2017) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-017-0196-x · Cited by 98
Wilkes‐Gillan, S., Bundy, A. C., Cordier, R., Lincoln, M., & Chen, Y.-W. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160558 · Cited by 116
“Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent developmental disorders [1, 2].”
Mulraney, M., Arrondo, G., Musullulu, H., Iturmendi-Sabater, I., Cortese, S., Westwood, S. J., Donno, F., Banaschewski, T., Simonoff, E., Zuddas, A., et al. (2022) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2021.11.031 · Cited by 81
The relationship between ADHD and obesity: implications for therapy
Cortese, S., & Castellanos, F. X. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.904748 · Cited by 80
“Its estimated worldwide-pooled prevalence is around 5% in school-age children, as found in a 2007 meta-analysis [5] that was recently updated [6].”
BackgroundThe role of epigenetic modifications in neurodevelopmental disorders: A systematic review
Dall’Aglio, L., Muka, T., Cecil, C. A. M., Bramer, W. M., Verbiest, M. M. P. J., Nano, J., Hidalgo, A. C., Franco, O. H., & Tiemeier, H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.011 · Cited by 78
“, 2011), highlighting the need for careful explorations of pathways to disorder etiology; although higher rates might result from confounding factors such as increased disorder awareness and methodological issues (American Psychiatric Association, 2013; Polanczyk et al., 2014).”
BackgroundBipolar Disorder and ADHD: Comorbidity and Diagnostic Distinctions
Marangoni, C., Chiara, L. D., & Faedda, G. L. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0604-y · Cited by 95
Areces, D., Rodríguez, C., García, T., Cueli, M., & González-Castro, P. (2018) · Journal of Attention Disorders · doi:10.1177/1087054716629711 · Cited by 77
“, 2012) and its high prevalence rates (Polanczyk et al., 2014), professionals must have reliable and valid instruments to diagnose this disorder.”
BackgroundLudyga, S., Gerber, M., Mücke, M., Brand, S., Weber, P., Brotzmann, M., & Pühse, U. (2020) · Journal of Attention Disorders · doi:10.1177/1087054718757647 · Cited by 78
Skoglund, C., Sundström Poromaa, I., Leksell, D., Ekholm Selling, K., Cars, T., Giacobini, M., Young, S., & Kopp Kallner, H. (2024) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13920 · Cited by 77
Yu, M., Gao, X., Niu, X., Zhang, M., Yang, Z., Han, S., Cheng, J., & Zhang, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1070142 · Cited by 124
Schiariti, V., Mahdi, S., & Bölte, S. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13922 · Cited by 77
“ADHD affects 3% to 7% of children and adults worldwide.(14) The core symptoms are inattention, impulsivity, and hyperactivity which cause extensive difficulties in school,(15) work,(16) social,(17) and domestic life.”
BackgroundPrevalence of neurodevelopmental disorders among US children and adolescents in 2019 and 2020
Yang, Y., Zhao, S., Zhang, M., Xiang, M., Zhao, J., Chen, S., Wang, H., Han, L., & Ran, J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.997648 · Cited by 76
Rodríguez, C., Areces, D., García, T., Cueli, M., & González-Castro, P. (2018) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2018.06.003 · Cited by 75
Townes, P., Liu, C., Panesar, P., Devoe, D., Lee, S. Y., Taylor, G., Arnold, P. D., Crosbie, J., & Schachar, R. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231190494 · Cited by 75
“ADHD is characterized by developmentally inappropriate inattention, hyperactivity, and impulsivity (American Psychiatric Association [APA], 2013) and affects 5% to 7% of school-aged children (Polanczyk et al., 2014).”
BackgroundAn Examination of Relations Among Working Memory, ADHD Symptoms, and Emotion Regulation
Groves, N. B., Kofler, M. J., Wells, E. L., Day, T. N., & Chan, E. S. M. (2020) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-019-00612-8 · Cited by 75
The association between the quantity and severity of pornography use: a meta-analysis
Chen, L., Jiang, X., Wang, Q., Bőthe, B., Potenza, M. N., & Wu, H. (2022) · The Journal of Sex Research · doi:10.1080/00224499.2021.1988500 · Cited by 72
“…DFFITS value, Cook’s distances, covariance ratios, estimates of τ2 and test statistics for (residual) heterogeneity] (Alemayehu & Hailemariam, 2020; Gallo et al., 2020; Polanczyk et al., 2014; Raboisson et al., 2020; Da Silva Chaves et al., 2018; Simental-Mendía et al., 2018; Wolfgang, 2010).”
BackgroundParental Psychopathology in Families of Children with ADHD: A Meta-analysis
Cheung, K., & Theule, J. (2016) · Journal of Child and Family Studies · doi:10.1007/s10826-016-0499-1 · Cited by 89
Obstetric mode of delivery and attention-deficit/hyperactivity disorder: a sibling-matched study
Curran, E. A., Khashan, A. S., Dalman, C., Kenny, L. C., Cryan, J. F., Dinan, T. G., & Kearney, P. M. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw001 · Cited by 73
Relative age and ADHD symptoms, diagnosis and medication: a systematic review
Holland, J., & Sayal, K. S. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1229-6 · Cited by 99
A meta-analytic investigation of the impact of mindfulness-based interventions on ADHD symptoms
Xue, J., Zhang, Y., & Huang, Y. (2019) · Medicine · doi:10.1097/md.0000000000015957 · Cited by 76
“The pooled estimated prevalence of ADHD is around 5%.([2]) Although in the past it was suggested that most children with ADHD would recover in”
BackgroundMeasures of Retinal Structure and Function as Biomarkers in Neurology and Psychiatry
Silverstein, S. M., Demmin, D. L., Schallek, J. B., & Fradkin, S. I. (2020) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2020.100018 · Cited by 80
Cortese, S., Bellgrove, M. A., Brikell, I., Franke, B., Goodman, D. W., Hartman, C. A., Larsson, H., LEVIN, F. R., Ostinelli, E. G., Parlatini, V., et al. (2025) · World Psychiatry · doi:10.1002/wps.21374 · Cited by 114
“Although there is some varia-354 tion among studies due to methodological differences, most notably the application of impairment criteria, the prevalence of the disorder is similar across geographic regions 90,91 .”
Self-citationThe dopamine transporter role in psychiatric phenotypes
Salatino‐Oliveira, A., Rohde, L. A., & Hutz, M. H. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32578 · Cited by 98
Self-citationCía, A. H., Stagnaro, J. C., Aguilar Gaxiola, S., Vommaro, H., Loera, G., Medina-Mora, M. E., Sustas, S., Benjet, C., & Kessler, R. C. (2018) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-018-1492-3 · Cited by 72
Adami, P. E., Κουτλιάνος, Ν., Baggish, A. L., Bermon, S., Cavarretta, E., Deligiannis, A. P., Furlanello, F., Kouidi, E. J., Marques-Vidal, P. M., Niebauer, J., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab198 · Cited by 90
Association between ADHD and vision problems. A systematic review and meta-analysis
Bellato, A., Perna, J., Ganapathy, P. S., Solmi, M., Zampieri, A., Cortese, S., & Faraone, S. V. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01699-0 · Cited by 87
Delgado‐Lobete, L., Pértega-Díaz, S., Santos-del-Riego, S., & Montes‐Montes, R. (2020) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2020.103608 · Cited by 93
“While prevalence rates vary across countries and definitions, it is estimated that DCD is present in at least 6% of schoolchildren, while ADHD prevalence is up to 9.5 % (Blank et al., 2019; Polanczyk, Willcutt, Salum, Kieling, & Rohde, 2014).”
InfluentialA serious game for children with Attention Deficit Hyperactivity Disorder: Who benefits the most?
Bul, K. C. M., Doove, L. L., Franken, I. H. A., Oord, S. V. D., Kato, P. M., & Maras, A. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193681 · Cited by 71
Baijot, S., Slama, H., Söderlund, G., Dan, B., Deltenre, P., Colin, C., & Deconinck, N. (2016) · Behavioral and Brain Functions · doi:10.1186/s12993-016-0095-y · Cited by 71
Quintero, J., Gutiérrez-Casares, J. R., & Álamo, C. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00392-2 · Cited by 70
Hartz, I., Skurtveit, S. O., Steffenak, A. K. M., Karlstad, Ø., & Handal, M. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0716-x · Cited by 83
“There is a higher prevalence of stimulant use in boys compared to girls, which is in accordance with studies on prevalences of ADHD-disorders [43], and drug use [9].”
BackgroundResultHeidbreder, R. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-015-0171-4 · Cited by 90
Karlstad, Ø., Furu, K., Stoltenberg, C., Håberg, S. E., & Bakken, I. J. (2017) · Scandinavian Journal of Public Health · doi:10.1177/1403494817708080 · Cited by 84
“[1] Polanczyk GV, Willcutt EG, Salum GA, et al.”
BackgroundExploring N -Back Cognitive Training for Children With ADHD
Jones, M. R., Katz, B., Buschkuehl, M., Jaeggi, S. M., & Shah, P. (2020) · Journal of Attention Disorders · doi:10.1177/1087054718779230 · Cited by 64
Silk, T. J., Genc, S., Anderson, V. A., Efron, D., Hazell, P., Nicholson, J. M., Kean, M. J., Malpas, C. B., & Sciberras, E. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0770-4 · Cited by 75
“Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of childhood, affecting 5 % of school-age children [1].”
BackgroundWang, L.-J., Lee, S.-Y., Yuan, S.-S., Yang, C.-J., Yang, K.-C., Huang, T.-S., Chou, W.-J., Chou, M.-C., Lee, M.-J., Lee, T.-L., et al. (2017) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796016000500 · Cited by 68
“2015), and these rates were not affected by the changes of diagnostic criteria from different versions of the Diagnostic and Statistical Manual of Mental Disorders, or geographical and chronological variations (Polanczyk et al. 2014).”
BackgroundInfluentialSkoglund, C., Kopp Kallner, H., Skalkidou, A., Wikström, A.-K., Lundin, C., Hesselman, S., Wikman, A., & Sundström Poromaa, I. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.12463 · Cited by 67
Rushton, S., Giallo, R., & Efron, D. (2019) · British Journal of Educational Psychology · doi:10.1111/bjep.12316 · Cited by 101
Diagnostic efficiency of the SDQ for parents to identify ADHD in the UK: a ROC analysis
Algorta, G. P., Dodd, A., Stringaris, A. K., & Youngstrom, E. A. (2016) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-015-0815-0 · Cited by 82
“Attention-deficit/hyperactivity disorder (ADHD) affects 3 % of boys and 1 % of girls in the United Kingdom [1] and an estimated 5–7 % of children globally [2–4].”
BackgroundDaley, D., Jacobsen, R. H., Lange, A.-M., Sørensen, A., & Walldorf, J. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2019.06.011 · Cited by 67
“The lifetime prevalence of ADHD is now widely acknowledged[5], and while some studies suggest that ADHD in adulthood may be different”
BackgroundGraziano, P. A., Garcia, A. M., & Landis, T. D. (2020) · Journal of Attention Disorders · doi:10.1177/1087054718770009 · Cited by 46
Pediatric sleep: current knowledge, gaps, and opportunities for the future
Reynolds, A. M., Spaeth, A. M., Hale, L., Williamson, A. A., LeBourgeois, M. K., Wong, S. D., Hartstein, L. E., Levenson, J. C., Kwon, M., Hart, C. N., et al. (2023) · SLEEP · doi:10.1093/sleep/zsad060 · Cited by 68
“The prevalence of sleep disturbances and disorders in youth with ADHD is high, ranging from 25% to 70% [209].”
BackgroundBenzing, V., & Schmidt, M. (2017) · BMC Pediatrics · doi:10.1186/s12887-016-0757-9 · Cited by 82
“ADHD is one of the most common disorders in childhood and adolescence with an estimated prevalence of 3–7% [2, 3], affecting more boys than girls [4].”
BackgroundCardiovascular Effects of ADHD Therapies
Torres-Acosta, N., O’Keefe, J. H., O’Keefe, C. L., & Lavie, C. J. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.081 · Cited by 65
Ke, H., Wang, F., Ma, H., & He, Z. (2022) · Knowledge-Based Systems · doi:10.1016/j.knosys.2022.109082 · Cited by 72
Avcil, S. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12659 · Cited by 65
“3%.(3) Although the cause and pathophysiology of ADHD are still not fully understood, the immune system is known to have a role in affecting the brain and behavior through established biological mechanisms.”
BackgroundA network analysis approach to ADHD symptoms: More than the sum of its parts
Silk, T. J., Malpas, C. B., Beare, R., Efron, D., Anderson, V., Hazell, P., Jongeling, B., Nicholson, J. M., & Sciberras, E. (2019) · PLOS ONE · doi:10.1371/journal.pone.0211053 · Cited by 65
Bigelow, H., Gottlieb, M., Ogrodnik, M., Graham, J. D., & Fenesi, B. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.660845 · Cited by 79
“AttentionDeficit Hyperactivity Disorder (ADHD) is one of themost common neurodevelopmental disorders affecting ∼6% of children worldwide (Polanczyk et al., 2014).”
BackgroundInfluentialThe Attention Network Test Database: ADHD and Cross-Cultural Applications
Arora, S., Lawrence, M. A., & Klein, R. M. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00388 · Cited by 69
Sex Differences in Neurodevelopmental Disorders: A Key Role for the Immune System
Breach, M. R., & Lenz, K. M. (2022) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2022_308 · Cited by 62
Trends in Subthreshold Psychiatric Diagnoses for Youth in Community Treatment
Safer, D. J., Rajakannan, T., Burcu, M., & ZITO, J. M. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1746 · Cited by 63
“1% of the diagnostic category total; (7) PDD NOS decreased prominently as FC autistic disorder increased; and (8) learning disorder NOS rose from 15.”
Hemamy, M., Pahlavani, N., Amanollahi, A., Islam, S. M. S., McVicar, J., Askari, G., & Malekahmadi, M. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-02631-1 · Cited by 95
“to 7% of school-age children have ADHD [5, 6].”
BackgroundKoblan, K. S., Hopkins, S. C., Sarma, K., Jin, F., Goldman, R., Kollins, S. H., & Loebel, A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.124 · Cited by 62
“ADHD affects 5–7% of children (based on DSM-IVTR criteria; Polanczyk et al, 2014), and frequently persists into adulthood, with prevalence estimates of 4% in adults (Faraone and Biederman, 2005; Kessler et al, 2006).”
BackgroundKnecht, C., de Alvaro, R., Martinez-Raga, J., & Balanza-Martinez, V. (2015) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2015-5007 · Cited by 62
“Int J Adolesc Med Health 2015; 27(2): 163–175”
Drover, S. S. M., Villanger, G. D., Aase, H., Skogheim, T. S., Longnecker, M. P., Zoeller, R. T., Reichborn‐Kjennerud, T., Knudsen, G. P., Zeiner, P., & Engel, S. M. (2018) · Epidemiology · doi:10.1097/ede.0000000000000937 · Cited by 74
Muñoz-Organero, M., Powell, L., Heller, B. W., Harpin, V., & Parker, J. C. (2018) · Sensors · doi:10.3390/s18113924 · Cited by 73
“Attention deficit and hyperactivity disorder (ADHD) is a neurodevelopmental disorder, which affects 3 to 5% of school-aged children [1,2].”
BackgroundQuintero, J., Ramos‐Quiroga, J. A., Sebastián, J. S., Rada, F. M., Fernández‐Jaén, A., Martínez-Raga, J., Giral, M. G., Graell, M., Mardomingo, M. J., Soutullo, C. A., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-017-1581-y · Cited by 71
A Potential Role for Neuroinflammation in ADHD
Vázquez-González, D., Carreón-Trujillo, S., Álvarez‐Arellano, L., Abarca-Merlin, D. M., Domínguez-López, P., Salazar–García, M., & Corona, J. C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_15 · Cited by 71
Baweja, R., Mattison, R. E., & Waxmonsky, J. G. (2015) · Pediatric Drugs · doi:10.1007/s40272-015-0144-2 · Cited by 61
“Attention-deficit hyperactivity disorder (ADHD) affects an estimated 5–7 % of schoolchildren worldwide [1, 2].”
BackgroundPadilha, S. C., Virtuoso, S., Tonin, F. S., Borba, H. H. L., & Pontarolo, R. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1125-0 · Cited by 73
ADHD prevalence estimates in Italian children and adolescents: a methodological issue
Reale, L., & Bonati, M. (2018) · Italian Journal of Pediatrics · doi:10.1186/s13052-018-0545-2 · Cited by 61
Jangmo, A., Kuja‐Halkola, R., Pérez-Vigil, A., Almqvist, C., Bulik, C. M., D'Onofrio, B. M., Lichtenstein, P., Ahnemark, E., Werner‐Kiechle, T., & Larsson, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247724 · Cited by 73
“Attention-deficit/hyperactivity disorder (ADHD) is a prevalent, childhood-onset neurodevelopmental disorder affecting around 5 percent of children [1], and 2.”
BackgroundLarsson, I., Aili, K., Lönn, M. E., Svedberg, P., Nygren, J., Ivarsson, A., & Johansson, P. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.12.021 · Cited by 77
Maternal fever during pregnancy and offspring attention deficit hyperactivity disorder
Gustavson, K., Ask, H., Ystrøm, E., Stoltenberg, C., Lipkin, W. I., Surén, P., Håberg, S. E., Magnus, P. M., Knudsen, G. P., Eilertsen, E. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45920-7 · Cited by 66
Caspersen, I. H., Aase, H., Biele, G., Brantsæter, A. L., Haugen, M. A., Kvalem, H. E., Skogan, A. H., Zeiner, P., Alexander, J., Meltzer, H. M., et al. (2016) · Environment International · doi:10.1016/j.envint.2016.06.033 · Cited by 64
ADHD symptoms and their neurodevelopmental correlates in children born very preterm
Montagna, A., Karolis, V. R., Batallé, D., Counsell, S. J., Rutherford, M., Arulkumaran, S., Happe, F. G. E., Edwards, A. D., & Nosarti, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0224343 · Cited by 75
Metadata
- Authors
- Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A.
- Affiliations
- Universidade Federal do Rio Grande do Sul (BR)
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-24
- Volume
- 43
- Issue
- 2
- Pages
- 434-442
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- PMC
- PMC4817588
- OpenAlex
- W2127901933
- Semantic Scholar
- 49eed63a8f5e937ec836d62f79aeeb8cd9c33805
- Cited by
- 1,822
- References
- 28
- Citations by year
- 2026: 137 · 2025: 184 · 2024: 168 · 2023: 188 · 2022: 184 · 2021: 170 · 2020: 180 · 2019: 140 · 2018: 154 · 2017: 111 · 2016: 102 · 2015: 76 · 2014: 24
- FWCI
- 14.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- International Journal of Epidemiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH063941, R01MH062120)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD068728, R01HD047264)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- attention deficit hyperactivity disorder, ADHD prevalence, temporal trends, diagnostic criteria, information sources, methodological heterogeneity, children, community prevalence
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Epidemiologic Methods, Humans, Time Factors, Global Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.